.png)
Where Financial Intelligence meets Healthcare Market Intelligence.
300+ healthcare organizations in Colombia analyzed. Intelligence for smarter decisions.
.png)
VALUE PROPOSITION
1. Combining Healthcare market intelligence with advanced financial analytics to deliver deeper insights for investors, healthcare providers, pharmaceutical companies, and medical device manufactures.
2. Financial Intelligence Beyond Traditional Analytic.
We combine quantitative finance, forensic analytics, and statistical modeling to uncover hidden risks, assess enterprise value, and empower confident, evidence-based decisions.
We uncover financial risks and business value that traditional analysis fails to detect.
QUANTITATIVE FINANCIAL ADVISORY
VALUATION, FORENSICS & CREDIT ANALYTICS
We determine what a company is truly worth — not what the market hopes, not what management projects, and not what a spreadsheet casually suggests.
Our valuation framework integrates:
-
Advanced discounted cash flow modeling
-
Risk-structured WACC calibration
-
Capital allocation efficiency analysis
-
Industry structural positioning
-
Scenario-based stress testing
-
Downside protection modeling
We challenge assumptions. We deconstruct projections. We pressure-test growth narratives.
This is not a template valuation.
This is capital-grade analysis.
Deliverable: A defensible, investment-level valuation built to withstand scrutiny from private equity, institutional investors, boards, and litigation environments.
SOLUTIONS.....
CORPORATE FINANCE & HEALTHCARE MARKET INTELLIGENCE
Global Health Intelligence
Trusted Across Latin America
Financial Intelligence • Market Intelligence • Healthcare Analytics
Selected Research & Publications.....
Selected research, financial intelligence and strategic analysis in the healthcare industry.
In the second installment of our exclusive financial analysis, led by Germán Chaparro of Proyekta Data Solutions, we dive deep into the critical liquidity crisis facing Health Service Providing Institutions (IPS, by its Spanish acronym). After analyzing a sample of 53 private IPSs, the data reveals a harsh reality for medical device manufacturers and technology providers: the rapid deterioration of hospital cash flows is drastically halting the sector’s modernization.
Today, IPSs are operating at their absolute limit, becoming involuntary financiers of a system that is stifling their capacity to invest.
US Healthcare Valuation.....
Public-market valuation benchmarks for leading U.S. healthcare providers.
Copyright © 2026 Proyekta Data Solutions. All rights reserved.
The proprietary methodology, analytical frameworks, models, evaluation criteria, algorithms, processes, and related know-how developed by Proyekta Data Solutions constitute the exclusive intellectual property of the Company and are protected under applicable intellectual property laws.
Proyekta Data Solutions maintains a highly selective client base. Access to its proprietary methodology and analytical outputs is granted exclusively to authorized clients for their internal business purposes. No part of the methodology, underlying analytical approach, or proprietary intellectual property may be reproduced, disclosed, distributed, modified, reverse engineered, commercialized, or used for the benefit of any third party without the prior written consent of Proyekta Data Solutions.
The delivery of reports or analytical outputs does not grant any ownership, license, or other rights over Proyekta Data Solutions' proprietary methodologies or intellectual property.